According to the National Institutes of Health, biofilms are estimated to account for over 80% of all nosocomial infections and are particularly common with device implants, such as contact lenses, ventricular assist devices, vascular, and urinary catheters, and endotracheal tubes. [2] [3] [4] P. aeruginosa forms a highly virulent biofilm that has been associated with higher mortality rates compared with other bacterial pathogens, and there are growing concerns over its increased antimicrobial and multidrug resistance. Because the use of conventional antimicrobial compounds in many cases cannot eradicate biofilms, there is an urgent need to develop alternative compounds and approaches to combat biofilm-based infections. [5] [6] [7] [8] [9] One frequently studied target is the bacterial membrane. Most antimicrobial peptides display broad-spectrum antibacterial activities and target the bacterial membrane. However, many antimicrobial peptides are difficult to synthesize and purify due to their complexity and size. In addition, antimicrobial peptides can be substrates for proteases, which limit their in vivo half-lives. 10 Recently, a series of cationic derivatives of cholic acid have 
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CSAs which stand for cationic steroidal antimicrobials are strongly associated with anionic cell surfaces and in formation of transient pores in the membrane resulting in membrane depolarization and cell death. As well as their antibacterial activities against resistant strains of (P. aeruginosa, Acinetobacter baumannii, Staphyloccoccus aures), these molecules can also display candidacidal, antiviral, antiparasitic and anticancer effects. [12] [13] [14] [15] [16] [17] [18] Additionally, previous studies have demonstrated that the efficacy of ceragenins, especially leading ceragenin CSA-13, on sessile cells including P. aeruginosa.
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However, here has been no study in the literature describing the efficacy of CSA-44 and CSA-131 against P. aeruginosa biofilms. This work examines the in vitro antibiofilm activities of CSA-13, CSA-44, CSA-131 and CSA-138 in comparison to colistin and ciprofloxacin against P. aeruginosa strains.
Material and Methods

Bacterial isolates
A total of 25 P. aeruginosa isolates from various sources including blood, aeruginosa ATCC 27853 strain was used as quality control strain.
Antimicrobial agents
CSAs, CSA-13, CSA-44, CSA-131 and CSA-138 were synthesized from a cholic acid scaffold technique as previously described (Figure 1 ). 19 Colistin and 
Media
Tryptic soy broth supplemented with 1% glucose (TSB-glucose, Difco
Laboratories, Franklin Lakes, NJ) was used for biofilm production and to determine Minimum biofilm eradication concentration (MBEC) values, CAMHB was used to determine the minimum inhibitory concentration (MIC) and tryptic soy agar (TSA, Difco Laboratories) was used culturing bacteria.
Minimum inhibitory concentration (MIC) determinations
MICs of CSA-13, CSA-44, CSA-131, CSA-138, ciprofloxacin and colistin were determined against P. aeruginosa (planktonic forms) by the microbroth dilution technique as described by CLSI.
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MIC50 is the MIC that inhibits 50% of isolates.
Biofilm formation
Biofilm formation by P. aeruginosa strains was evaluated using a crystal violet staining method. 21, 22 Briefly, populations of suspensions of bacteria were adjusted with TSB-glucose. Biofilms were formed by pipetting cell suspensions into wells of microtitre plates (Greiner Bio-One, Kremsmuenster, Austria) followed by incubation for 24 h at 37 °C. After incubation, the remaining medium was aspirated gently, non-adherent cells were removed and wells were stained with 0.1% crystal violet, followed by measurement of optical density at 600 nm. For each isolate, biofilm production was measured in triplicate and P. aeruginosa 
Biofilm attachment assay
Biofilm attachment assays were performed using a previously described method with some modifications. 22, 23 The overnight cultures of isolates were prepared to cellular density equivalent to 1x10 6 cells/ml, as described above. Four strong biofilm producing clinical isolates of P. aeruginosa were added to each well of 96-well tissue culture microtitre plates with 1xMIC of CSAs and antibiotics. Positive control without antimicrobial agent and negative control without cells were also prepared. The plates were incubated for 1, 2 and 4 h at 37 ˚C. After incubation, the wells were washed twice with PBS and were measured spectrophotometrically at optical density (OD) 450 nm on a microplate reader (BioRad Novapath).
Inhibition of biofilm formation
Four strong biofilm producing clinical isolates P. aeruginosa strains (1x10 6 cells/ml) were added to each well of 96-well tissue culture microtitre plate with 1xMIC, 1/10xMIC and 1/100x MIC of ceragenins and antibiotics. 22, 23 The positive control without antimicrobial agent and negative control without cells were prepared. The plates were incubated for 24 at 37˚C. After incubation, the wells were washed twice with PBS and were measured spectrophotometrically at OD 450 nm, on a microplate reader (BioRad Novapath).
Minimum biofilm eradication concentration (MBEC) determinations u n c o r r e c t e d p r o o f
To evaluate the activities of antimicrobial agents on 24 h old mature P.
aeruginosa biofilms, biofilms were formed as described above and metabolic activities of the biofilms were assessed using the standardized static microtitre Louis, MO, USA) reduction assay. 24 The 24-h biofilms in a 96-well tissue culture microtitre plates were washed three times with 200 µl PBS solution and air-dried.
Doubling concentrations of antimicrobials were added to the pre-formed biofilms.
Aliquots of 200 µl of each concentration were added to each corresponding well and plates were incubated 24 h at 37 °C. Drug-free biofilm wells containing only TSB-glucose were used as controls. After incubation, the medium was aspirated and washed with PBS three times. An XTT solution was prepared as previously published and added to each well. Microtitre plates were incubated in the dark for 6 h at 37°C. Biofilm growth was measured spectrophotometrically at 480 nm on microplate reader (BioRad Novapath). MBECs were determined as the minimum antibacterial drug concentration that caused 50% reduction of biofilm compared to drug-free untreated biofilm controls. Each experiment was performed in four wells and was repeated two times.
Results
Susceptibility results against planktonic cells (MIC)
The in vitro activities of the studied antimicrobials against 25 P. aeruginosa are summarized in 
Inhibition of adhesion
Inhibition of adhesion rates depended on time. CSA-13, CSA-44 and CSA-131
were found more efficient after 4 h incubation although CSA-138, ciprofloxacin 
Inhibition of biofilm formation
Inhibition of biofilm formation rates depended at concentration; the highest inhibition rates were shown at MICs for all agents, as expected. CSA-131, CSA-138 and colistin were found most efficient agents for inhibition of biofilm formation (up to 90%) ( Figure 3 ).
Susceptibility results against biofilm cells (MBEC)
We showed that ceragenins are also active against four biofilm producing clinical Ciprofloxacin and colistin were showed similar MBEC values (8-64 µg/ml) ( Table   2 ). Among the tested ceragenins, CSA-13 was found the most effective agent against mature biofilms.
Discussion
Ceragenins are unique, low-molecular-mass, cationic steroid compounds. These compounds mimic the activity of naturally occurring antimicrobial peptides.
Previous studies have shown that ceragenins especially, CSA-13 is a potent antimicrobial against various microorganisms including multidrug-resistant P.
aeruginosa. [11] [12] [13] In this work, in addition to CSA-13, we investigated the effect of In the present study, MBECs of ceragenins and antibiotics were found higher than MICs, as expected. Ciprofloxacin and colistin's MBECs were found less than ceragenins, however, among ceragenins CSA 13 was found the most effective agent against mature biofilms. In contrast to the antimicrobial effects against bacteria and fungi, the antibiofilm activity of ceragenins is not well defined against biofilms. Only few studies showed that ceragenins especially CSA-13 have antibiofilm effects against on P.
aeruginosa. [26] [27] [28] Novel approaches to biofilm control might take one of three main forms: effective reduction of planktonic cells before biofilm formation, inhibition of cell adhesion and biofilm formation or removal of established biofilm. Nagant et al. 26, 28 have demonstrated that CSA-13 effected the biofilm formation, surface of biofilms and also inside of the established biofilms of P. aeruginosa.
Gu et al. 27 were showed that CSA-138 also inhibited biofilm formation of P.
aeruginosa on lenses. Our results were similar with these studies.
Conclusion
To our knowledge this is the first report evaluated the antibiofilm activities of the 
